3DT HOLDINGS, LLC

San Diego, CA · Medtech · Private

Fecobionics, a multimodal anorectal diagnostic device that measures pressures, orientation, bending, and shape during defecation to assess sphincter function and anorectal mechanics

Claim this profile

Follows are private to you and power your alerts

Updated · 3dtholdings.com

Sector
Medtech
Headquarters
San Diego, CA
Total capital
$21.3M
Federal grants
$21.3M
30 awards · 2015–2026
Rank in peer group#11 of 538
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
29
11 pending · first 2019
Rank in peer group#8 of 538

Capital timeline

201520172019202120232025FEDERAL ↑EQUITY ↓Cumulative $21.3M$2M$1.2M$2.4M$1.9M$1.1M
201520172019202120232025FEDERAL ↑EQUITY ↓Cumulative $21.3M$2M$2.4M$1.9M

Latest events

  • Federal grantHealth and Human S · Phase II · Software-guided Operative Planning of MitraClip Placement$1.1M
  • Federal grantHealth and Human S · Phase II · Software-guided Operative Planning of MitraClip Placement$1.1M
  • Federal grantHealth and Human S · Phase II · Software-guided Operative Planning of MitraClip Placement$481K
  • Federal grantHealth and Human S · Phase I · Novel Stabilization Catheter for His Pacing Lead Implant$437K
  • Federal grantHealth and Human S · Phase I · Software Tool for Optimization of CRT$294K
  • Federal grantHealth and Human S · Phase I · Novel Tracheostoma Device$400K
  • Federal grantHealth and Human S · Phase I · Low Profile Transcatheter Aortic Valve Implant$497K
Show 23 earlier federal awards
  • Federal grantHealth and Human S · Phase II · Biomechatronics Device for Diagnosis/Therapy of Anorectal Disorders$854K
  • Federal grantHealth and Human S · Phase II · Biomechatronics Device for Diagnosis/Therapy of Anorectal Disorders$1.9M
  • Federal grantHealth and Human S · Phase II · Biomechatronics Device for Diagnosis/Therapy of Anorectal Disorders$186K
  • Federal grantHealth and Human S · Phase I · New Access Kit for Lymphatic Interventions$340K
  • Federal grantHealth and Human S · Phase I · Vasodilation Needle for Trans-Radial Access$377K
  • Federal grantHealth and Human S · Phase I · Left Atrial Appendage Inversion to Prevent Stroke$366K
  • Federal grantHealth and Human S · Phase I · HLS-Diagnostic Balloon in Novel Venous Disease Model$364K
  • Federal grantHealth and Human S · Phase I · Small Peripheral Vessel Graft$326K
  • Federal grantHealth and Human S · Phase I · Real-Time Virtual Assessment of MitraClip Placement$290K
  • Federal grantHealth and Human S · Phase II · Device for Treatment of Cardiac No-Option Patients$992K
  • Federal grantHealth and Human S · Phase I · Novel Leaflet Biomaterial for Pulmonary Artery Valve$447K
  • Federal grantHealth and Human S · Phase I · Novel Biological Tissue for Vascular Patch$419K
  • Federal grantHealth and Human S · Phase II · Device for Treatment of Cardiac No-Option Patients$2.4M
  • Federal grantHealth and Human S · Phase II · Mild Hypothermia Catheter for Reperfusion Injury$1.1M
  • Federal grantHealth and Human S · Phase II · Suction Device for Control and Accuracy of Transseptal Access$1.2M
  • Federal grantHealth and Human S · Phase II · Mild Hypothermia Catheter for Reperfusion Injury$2M
  • Federal grantHealth and Human S · Phase I · Novel Fecobionics Device for Diagnosis of Anorectal Disorders$259K
  • Federal grantHealth and Human S · Phase I · Suction Device for Control and Accuracy of Transseptal Access$809K
  • Federal grantHealth and Human S · Phase I · HLS-Animal Model and Treatment of Chronic Venous Insufficiency$359K
  • Federal grantHealth and Human S · Phase I · Device for Treatment of Cardiac No-Option Patients$285K
  • Federal grantHealth and Human S · Phase II · Coronary Post-Dilatation Catheter$781K
  • Federal grantHealth and Human S · Phase II · Coronary Post-Dilatation Catheter$701K
  • Federal grantHealth and Human S · Phase I · Valvuloplasty Sizing Balloon Catheter$237K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#11 · top 2%
  • Granted patents#8 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 29 granted of 40
Show all 40 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .